|
N patients
|
298
|
17
|
|
Procedural duration in minutes, median (IQR)
|
121 (55)
|
108 (54)
|
|
Recanalization (TICI 2b and TICI 3)
|
113 (43 %)
|
6 (46 %)
|
|
Neurological recovery (decrease in NIHSS of 8 points or more), n (%)
|
9 (53 %)
|
8 (47 %)
|
|
Good functional outcome at discharge, mRS 0–2, n (%)
|
75 (25 %)
|
3 (18 %)
|
|
Death, n (%)
|
47 (16 %)
|
4 (26 %)
|
|
All adverse events, n (%)
|
164 (55 %)
|
13 (76 %)
|
|
Non-neurological adverse events, n (%)
|
91 (31 %)*
|
10 (59 %)*
|
|
Neurological adverse events, n (%)
|
113 (38 %)
|
6 (35 %)
|
|
Neurological serious adverse events, n (%)
|
44 (15 %)
|
3 (18 %)
|
